Journals / Turkish Neurosurgery / 2020 / Cilt: 30 - Sayı: 1

Nomograms for Predicting the Overall and Cancer-Specific Survival of Patients with High-Grade Glioma: A Surveillance, Epidemiology, and End Results Study

Pages
48–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

AIM: To predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with high-grade glioma (HGG) usingnomograms and the surveillance, epidemiology, and end results (SEER) database (2000-2013).MATERIAL and METHODS: A total of 3706 patients with high-grade glioma were identified by the SEER database (2000-2013).Based on the relevant information of these patients, we divided the primary cohort into a training cohort (n=3336) and a validationcohort (n=370).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: To predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with high-grade glioma (HGG) usingnomograms and the surveillance, epidemiology, and end results (SEER) database (2000-2013).MATERIAL and METHODS: A total of 3706 patients with high-grade glioma were identified by the SEER database (2000-2013).Based on the relevant information of these patients, we divided the primary cohort into a training cohort (n=3336) and a validationcohort (n=370).
📊
Key Findings & Data:The nomograms were constructed by the training cohort and corroborated by the validation cohort.RESULTS: According to the multivariate analysis of the training cohort, the nomograms of OS and CSS indicated that patient ageat diagnosis, laterality, radiation, and the extent of resection are significantly correlated with the survival rate.
💡
Conclusion & Impact:The calibration curve plots of 1- and 3-year OS and CSS showed that the nomogram predictions are consistentwith the observed outcomes for both the training and validation cohorts.CONCLUSION: Based on the data obtained, we established a scoring model to predict the OS and the CSS of patients with HGG.All calibration curves showed high consistency between the predicted and actual survival.
🔬Design:Modeling & Simulation
📍Scope:2000-2013 Verileri
⚙️Variables:Domain Parameters

Özet

AIM: To predict the overall survival (OS) and the cancer-specific survival (CSS) of patients with high-grade glioma (HGG) usingnomograms and the surveillance, epidemiology, and end results (SEER) database (2000-2013).MATERIAL and METHODS: A total of 3706 patients with high-grade glioma were identified by the SEER database (2000-2013).Based on the relevant information of these patients, we divided the primary cohort into a training cohort (n=3336) and a validationcohort (n=370). The nomograms were constructed by the training cohort and corroborated by the validation cohort.RESULTS: According to the multivariate analysis of the training cohort, the nomograms of OS and CSS indicated that patient ageat diagnosis, laterality, radiation, and the extent of resection are significantly correlated with the survival rate. The c-indexes of thenomograms of OS and CSS of the training cohort are 0.682 [95% confidence interval (CI): 0.671-0.693] and 0.678 (95%CI: 0.666-0.690), respectively. The calibration curve plots of 1- and 3-year OS and CSS showed that the nomogram predictions are consistentwith the observed outcomes for both the training and validation cohorts.CONCLUSION: Based on the data obtained, we established a scoring model to predict the OS and the CSS of patients with HGG.All calibration curves showed high consistency between the predicted and actual survival.

🔖

Cite This Article

XIA, Y., LIAO, W., HUANG, S., LIU, Z., HUANG, X., YANG, C., YE, C., JIANG, Y., WANG, J. (2020). Nomograms for Predicting the Overall and Cancer-Specific Survival of Patients with High-Grade Glioma: A Surveillance, Epidemiology, and End Results Study. Turkish Neurosurgery, Cilt: 30 - Sayı: 1, 48–59. https://ajindex.com/articles/405269

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M: Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: Does maximal resection of the tumor lengthen the median survival? World Neurosurg 73(2):128-134; discussion: e16, 2010 2. Balachandran VP, Gonen M, Smith JJ, DeMatteo RP: Nomograms in oncology: More than meets the eye. Lancet Oncol 16(4):e173-180, 2015 3. Barnholtz-Sloan JS, Maldonado JL, Williams VL, Curry WT, Rodkey EA, Barker FG 2nd, Sloan AE: Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 85(2):171-180, 2007 4. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ: Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9(5):453-461, 2008 5. Chang SM, Barker FG 2nd: Marital status, treatment, and survival in patients with glioblastoma multiforme: A population based study. Cancer 104(9):1975-1984, 2005 6. Fekete B, Werlenius K, Orndal C, Rydenhag B: Prognostic factors for glioblastoma patients-a clinical population-based study. Acta Neurol Scand 133(6):434-441, 2016 7. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R: Nomograms for predicting survival of patients with newly diagnosed glioblastoma: Prognostic factor analysis of EORTC and NCIC trial 26981- 22981/CE.3. Lancet Oncol 9(1):29-38, 2008 8. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15(4):361-387, 1996 9. Harsh GRt, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21(5):615-621, 1987 10. Huitzil-Melendez FD, Capanu M, O’Reilly EM, Duffy A, Gansukh B, Saltz LL, Abou-Alfa GK: Advanced hepatocellular carcinoma: Which staging systems best predict prognosis? J Clin Oncol 28(17):2889-2895, 2010 11. Kattan MW: Validating a prognostic model. Cancer 107(11):2523-2524, 2006 12. Khan L, Soliman H, Sahgal A, Perry J, Xu W, Tsao MN: External beam radiation dose escalation for high grade glioma. Cochrane Database Syst Rev 8:Cd011475, 2016 13. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K: Combined modality therapy of operated astrocytomas grade I